SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-041763
Filing Date
2022-02-14
Accepted
2022-02-14 16:17:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d35843dsc13g.htm SC 13G 47540
  Complete submission text file 0001193125-22-041763.txt   49023
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Subject) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93402 | Film No.: 22632270
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRUCE GRIPTON 4 HILL STREET LONDON X0 W1J 5NE
Business Address C/O BRUCE GRIPTON 4 HILL STREET LONDON X0 W1J 5NE 44 207 3181180
MWG Management Ltd. (Filed by) CIK: 0001845151 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G